JP5183853B2 - 二量体化合物および抗ウイルス薬としてのそれらの使用 - Google Patents

二量体化合物および抗ウイルス薬としてのそれらの使用 Download PDF

Info

Publication number
JP5183853B2
JP5183853B2 JP2003542181A JP2003542181A JP5183853B2 JP 5183853 B2 JP5183853 B2 JP 5183853B2 JP 2003542181 A JP2003542181 A JP 2003542181A JP 2003542181 A JP2003542181 A JP 2003542181A JP 5183853 B2 JP5183853 B2 JP 5183853B2
Authority
JP
Japan
Prior art keywords
compound
formula
acid
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003542181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510519A (ja
Inventor
マイケル、ディー、ドール
ベティー、ジン
サイモン、ジェイ．エフ．マクドナルド
アンドリュー、マックエム、メイソン
ダリル、マックコーネル
バン、ティー．ティー．グエン
スティーブン、イー．シャナハン
ウェン‐ヤン、ウー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR8798A external-priority patent/AUPR879801A0/en
Priority claimed from AUPS2600A external-priority patent/AUPS260002A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of JP2005510519A publication Critical patent/JP2005510519A/ja
Application granted granted Critical
Publication of JP5183853B2 publication Critical patent/JP5183853B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2003542181A 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用 Expired - Fee Related JP5183853B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPR8798 2001-11-09
AUPR8798A AUPR879801A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use
AUPS2600 2002-05-27
AUPS2600A AUPS260002A0 (en) 2002-05-27 2002-05-27 Novel chemical compounds and their use
PCT/AU2002/001524 WO2003040135A1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010161587A Division JP2010270130A (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Publications (2)

Publication Number Publication Date
JP2005510519A JP2005510519A (ja) 2005-04-21
JP5183853B2 true JP5183853B2 (ja) 2013-04-17

Family

ID=25646840

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003542181A Expired - Fee Related JP5183853B2 (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用
JP2010161587A Withdrawn JP2010270130A (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010161587A Withdrawn JP2010270130A (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Country Status (12)

Country Link
US (2) US7157494B2 (https=)
EP (1) EP1451182B1 (https=)
JP (2) JP5183853B2 (https=)
KR (1) KR100942492B1 (https=)
CN (1) CN1285591C (https=)
AT (1) ATE398122T1 (https=)
CA (1) CA2462337C (https=)
DE (1) DE60227100D1 (https=)
DK (1) DK1451182T3 (https=)
ES (1) ES2305300T3 (https=)
PT (1) PT1451182E (https=)
WO (1) WO2003040135A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157494B2 (en) * 2001-11-09 2007-01-02 Biota Scientific Management Pty. Ltd. Dimeric compounds and their use as anti-viral agents
US7317122B2 (en) 2004-12-04 2008-01-08 Xerox Corporation Curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7144450B2 (en) 2004-12-04 2006-12-05 Xerox Corporation Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds
US7314949B2 (en) 2004-12-04 2008-01-01 Xerox Corporation Trans-1,2-cyclohexane bis(urea-urethane) compounds
US7153349B2 (en) 2004-12-04 2006-12-26 Xerox Corporation Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7560587B2 (en) 2004-12-04 2009-07-14 Xerox Corporation Bis[urea-urethane] compounds
US7576235B2 (en) 2004-12-04 2009-08-18 Xerox Corporation Processes for preparing bis(urea-urethane) compounds
US7220300B2 (en) 2004-12-04 2007-05-22 Xerox Corporation Phase change inks containing bis(urea-urethane) compounds
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
CN108003065B (zh) * 2016-10-27 2021-01-08 中国石油化工股份有限公司 一种具有增稠作用的化合物和润滑脂以及它们的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
HU223099B1 (hu) * 1996-03-01 2004-03-29 Biota Scientific Managemant Pty. Ltd. Eljárás influenzavírus kimutatására és az eljárásban alkalmazható vegyületek
US6153442A (en) * 1998-05-20 2000-11-28 Dade Behring Inc. Reagents and methods for specific binding assays
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US7157494B2 (en) * 2001-11-09 2007-01-02 Biota Scientific Management Pty. Ltd. Dimeric compounds and their use as anti-viral agents
JP2010027130A (ja) 2008-07-17 2010-02-04 Sony Corp 装着機構および出力装置

Also Published As

Publication number Publication date
WO2003040135A1 (en) 2003-05-15
EP1451182A4 (en) 2005-02-02
JP2010270130A (ja) 2010-12-02
US20070293564A1 (en) 2007-12-20
ATE398122T1 (de) 2008-07-15
CA2462337A1 (en) 2003-05-15
DE60227100D1 (de) 2008-07-24
JP2005510519A (ja) 2005-04-21
US20050038108A1 (en) 2005-02-17
CN1285591C (zh) 2006-11-22
KR20050044337A (ko) 2005-05-12
EP1451182A1 (en) 2004-09-01
DK1451182T3 (da) 2008-10-27
US7157494B2 (en) 2007-01-02
CA2462337C (en) 2011-09-27
PT1451182E (pt) 2008-09-17
HK1068346A1 (en) 2005-04-29
KR100942492B1 (ko) 2010-02-12
ES2305300T3 (es) 2008-11-01
CN1585765A (zh) 2005-02-23
EP1451182B1 (en) 2008-06-11

Similar Documents

Publication Publication Date Title
JP2010270130A (ja) 二量体化合物および抗ウイルス薬としてのそれらの使用
JP5095066B2 (ja) 多価ノイラミニダーゼ阻害物質複合体
JP2010285436A (ja) 二量体化合物および抗ウイルス薬としてのそれらの使用
JP4162712B2 (ja) ６−カルボキサミドジヒドロピラン誘導体
JP5179546B2 (ja) 二量体化合物および抗ウイルス薬としてのそれらの使用
JP2011016804A (ja) 二量体化合物および抗ウイルス薬としてのそれらの使用
AU2002340632B2 (en) Dimeric compounds and their use as anti-viral agents
HK1068346B (en) Dimeric compounds and their use as anti-viral agents
AU2002340632A1 (en) Dimeric compounds and their use as anti-viral agents
AU2002336823A1 (en) Dimeric compounds and their use as anti-viral agents

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051013

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090529

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090831

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090929

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091029

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121127

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130116

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160125

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees